Abstract
Hypertension increases the risk of reinfarction and sudden death in the post-myocardial infarction patient, and the same also applies to the co-existing left ventricular hypertrophy (LVH). Thus the therapeutic aim in such patients are: (1) appropriate blood pressure (BP) control; (2) regression of LVH; and (3) secondary prevention to reduce long-term mortality. All of these goals can potentially be met by use of ACE inhibitors. However, achieving quality BP control demands appropriate selection of doses and dosage regimens. Trough : peak ratios are useful in determining duration of action and may thus offer a rational approach to aid the selection drug doses and dosage regimens.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Comparison of the efficacy and safety of azilsartan with that of candesartan cilexetil in Japanese patients with grade I–II essential hypertension: a randomized, double-blind clinical study
Hypertension Research Open Access 26 January 2012
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Meredith, P. Importance of trough : peak ratios in treatment of blood pressure in post-myocardial infarction and heart failure settings. J Hum Hypertens 11, 39–43 (1997). https://doi.org/10.1038/sj.jhh.1000399
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.jhh.1000399